Jinhe Biotechnology: If tariffs between China and the United States decrease, the company's export business of veterinary drugs will directly benefit.

Jinhe Biotech stated on May 13th on the interactive platform that if Sino-US tariffs decrease, the company's export business of veterinary pharmaceuticals will directly benefit. Currently, the company has already increased terminal market prices to effectively cover the increased cost of tariffs.